![Jose Carmona](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jose Carmona
Finanzdirektor/CFO bei
ADC THERAPEUTICS SA
Vermögen: 1 Mio $ am 31.10.2026
Profil
Jose Carmona is currently Director at HotSpot Therapeutics, Inc. and Chief Financial Officer at ADC Therapeutics SA since 2022.
Former roles include Director at Senda Biosciences, Inc.; Chief Financial Officer, Treasurer & Senior VP at Radius Health, Inc. from 2017 to 2020; Chief Financial & Accounting Officer at Rubius Therapeutics, Inc. from 2020 to 2022; Chief Financial Officer at Innocoll AG and Innocoll Biotherapeutics Holdings Ltd. from 2015 to 2017; CFO-Alcon Europe, Middle East & Africa at Novartis AG from 2013 to 2015; and Chief Financial Officer at Alcon AG.
Education includes an undergraduate degree from Universidad Técnica Federico Santa María and an MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 0.73% | 30.06.2026 | 938’076 ( 0.73% ) | 1 Mio $ | 31.10.2026 |
Aktive Positionen von Jose Carmona
| Unternehmen | Position | Beginn |
|---|---|---|
| ADC THERAPEUTICS SA | Finanzdirektor/CFO | 19.12.2022 |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jose Carmona
| Unternehmen | Position | Ende |
|---|---|---|
| RUBIUS THERAPEUTICS | Finanzdirektor/CFO | 15.11.2022 |
| RADIUS HEALTH, INC. | Finanzdirektor/CFO | 24.09.2020 |
| INNOCOLL HOLDINGS PLC | Finanzdirektor/CFO | 01.05.2017 |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Finanzdirektor/CFO | 01.01.2017 |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Jose Carmona
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Alcon AG
 Alcon AG Medical SpecialtiesHealth Technology Develops, manufactures and distributes surgical & eye care devices | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Universidad Técnica Federico Santa María
 Universidad Técnica Federico Santa María Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Health Technology |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
